Status: current, Defined. Date: 31-Oct 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4631371000168115 | Xevudy (sotrovimab 500 mg / 8 mL) injection, 8 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4631381000168117 | Xevudy 500 mg/8 mL injection, 8 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Xevudy 500 mg/8 mL injection, 8 mL vial | Is a | Xevudy | true | Inferred relationship | Some | ||
| Xevudy 500 mg/8 mL injection, 8 mL vial | Is a | sotrovimab 500 mg/8 mL injection, vial | true | Inferred relationship | Some | ||
| Xevudy 500 mg/8 mL injection, 8 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Xevudy 500 mg/8 mL injection, 8 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Xevudy 500 mg/8 mL injection, 8 mL vial | has unit of use | vial | true | Inferred relationship | Some | 387455057 | |
| Xevudy 500 mg/8 mL injection, 8 mL vial | has Australian BoSS | sotrovimab | true | Inferred relationship | Some | 1962036602 | |
| Xevudy 500 mg/8 mL injection, 8 mL vial | has intended active ingredient | sotrovimab | true | Inferred relationship | Some | 1962036602 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Xevudy 500 mg/8 mL injection, 8 mL vial | has TPUU | True | Xevudy 500 mg/8 mL injection, 8 mL vial | Inferred relationship | Some | 1937302733 |
| Xevudy 500 mg/8 mL injection, 8 mL vial | has TPUU | True | Xevudy 500 mg/8 mL injection, 8 mL vial | Inferred relationship | Some | 1061097974 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR